DrQuinn
09-16-2004, 06:12 PM
I read this article last year, and fell in love with it. Only could a study like this be done in Canada. Next time your medicine resident yells at you for not getting blood cultures in CAP, show them this. Unfortunately I can't c/p the full article (too many charts) but I got the abstract.
The contribution of blood cultures to the clinical management of adult patients admitted to the hospital with community-acquired pneumonia: a prospective observational study.
Campbell SG - Chest - 01-APR-2003; 123(4): 1142-50
From NIH/NLM MEDLINE
NLM Citation ID:
12684305 (PubMed)
Comment:
Chest. 2003 Apr;123(4):977-8
PubMed ID: 12684278
Full Source Title:
Chest
Publication Type:
Clinical Trial; Controlled Clinical Trial; Journal Article; Multicenter Study; Randomized Controlled Trial
Language:
English
Author Affiliation:
Department of Emergency Medicine, Dalhousie University, Halifax, NS, Canada. sgcampbe@is.dal.ca
Authors:
Campbell SG; Marrie TJ; Anstey R; Dickinson G; Ackroyd-Stolarz S
Abstract:
STUDY OBJECTIVE: To assess the clinical usefulness of blood cultures (BCs) in the management of patients hospitalized with community-acquired pneumonia (CAP). DESIGN: A prospective, observational study to investigate the contribution of BCs to the management and outcomes of adult patients presenting with CAP. SETTING: Nineteen Canadian hospitals. PATIENTS: Adults admitted to the hospital with CAP between January 1, 1998, and July 31, 1998. INTERVENTIONS: The courses of therapy in patients for whom BC results yielded organisms considered to be clinically significant were analyzed to determine whether the BCs had contributed to management or outcome. MEASUREMENTS AND RESULTS: Forty-three of 760 patients had significantly positive BC results. Patients with CAP who had BCs performed had a 1.97% chance (15 of 760 patients) of having a change of therapy directed by BC results. Patients in whom BCs yielded positive results had a 34.8% chance (15 of 43 patients) of having a change in therapy determined by BC results, and had a 58.1% chance (25 of 43 patients) of having a course of therapy contraindicated by BC results. Severity of illness, as measured by the pneumonia severity index, correlated poorly with the yield of BCs. BC results were positive in 8.0% of patients in risk classes I and II, 6.2% of patients in risk class III, 4.6% of patients in risk class IV, and 5.2% of patients in risk class V. CONCLUSION: BCs have limited usefulness in the routine management of patients admitted to the hospital with uncomplicated CAP.
The contribution of blood cultures to the clinical management of adult patients admitted to the hospital with community-acquired pneumonia: a prospective observational study.
Campbell SG - Chest - 01-APR-2003; 123(4): 1142-50
From NIH/NLM MEDLINE
NLM Citation ID:
12684305 (PubMed)
Comment:
Chest. 2003 Apr;123(4):977-8
PubMed ID: 12684278
Full Source Title:
Chest
Publication Type:
Clinical Trial; Controlled Clinical Trial; Journal Article; Multicenter Study; Randomized Controlled Trial
Language:
English
Author Affiliation:
Department of Emergency Medicine, Dalhousie University, Halifax, NS, Canada. sgcampbe@is.dal.ca
Authors:
Campbell SG; Marrie TJ; Anstey R; Dickinson G; Ackroyd-Stolarz S
Abstract:
STUDY OBJECTIVE: To assess the clinical usefulness of blood cultures (BCs) in the management of patients hospitalized with community-acquired pneumonia (CAP). DESIGN: A prospective, observational study to investigate the contribution of BCs to the management and outcomes of adult patients presenting with CAP. SETTING: Nineteen Canadian hospitals. PATIENTS: Adults admitted to the hospital with CAP between January 1, 1998, and July 31, 1998. INTERVENTIONS: The courses of therapy in patients for whom BC results yielded organisms considered to be clinically significant were analyzed to determine whether the BCs had contributed to management or outcome. MEASUREMENTS AND RESULTS: Forty-three of 760 patients had significantly positive BC results. Patients with CAP who had BCs performed had a 1.97% chance (15 of 760 patients) of having a change of therapy directed by BC results. Patients in whom BCs yielded positive results had a 34.8% chance (15 of 43 patients) of having a change in therapy determined by BC results, and had a 58.1% chance (25 of 43 patients) of having a course of therapy contraindicated by BC results. Severity of illness, as measured by the pneumonia severity index, correlated poorly with the yield of BCs. BC results were positive in 8.0% of patients in risk classes I and II, 6.2% of patients in risk class III, 4.6% of patients in risk class IV, and 5.2% of patients in risk class V. CONCLUSION: BCs have limited usefulness in the routine management of patients admitted to the hospital with uncomplicated CAP.